Literature DB >> 4260946

A suggested mechanism for the pathogenesis of infectious atrophic rhinitis.

D L Harris, W P Switzer, R A Harris.   

Abstract

Boivin extracts of Bordetella bronchiseptica inhibited or uncoupled the energized processes of bovine heart and pig heart mitochondria. Energy-dependent accumulation of calcium phosphate by both types of mitochondria was markedly inhibited by the extracts. The thesis is advanced that Boivin extracts of B. bronchiseptica may contain the membrane-damaging component responsible for infectious atrophic rhinitis. The action of the extracts was decreased by heat but seemed rather insensitive to digestion by trypsin or extraction by lipid solvents. Attempts to resolve the active component from the extracts were unsuccessful.

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 4260946      PMCID: PMC1319590     

Source DB:  PubMed          Journal:  Can J Comp Med        ISSN: 0008-4050


  19 in total

1.  Cell communication, calcium ion, and cyclic adenosine monophosphate.

Authors:  H Rasmussen
Journal:  Science       Date:  1970-10-23       Impact factor: 47.728

2.  Effect of Bordetella endotoxin upon mitochondrial respiration and energized processes.

Authors:  R A Harris; D L Harris; D E Green
Journal:  Arch Biochem Biophys       Date:  1968-10       Impact factor: 4.013

3.  Turbinate atrophy in young pigs exposed to Bordetella bronchiseptica, Pasteurella multocida, and combined inoculum.

Authors:  D L Harris; W P Switzer
Journal:  Am J Vet Res       Date:  1968-04       Impact factor: 1.156

4.  Pathology of experimental Bordetella bronchiseptica infection in swine: atrophic rhinitis.

Authors:  J R Duncan; R F Ross; W P Switzer; F K Ramsey
Journal:  Am J Vet Res       Date:  1966-03       Impact factor: 1.156

5.  Are mitochondria directly involved in biological mineralisation?

Authors:  I M Shapiro; J S Greenspan
Journal:  Calcif Tissue Res       Date:  1969

6.  Incidence of certain microorganisms in nasal cavities of swine in Iowa.

Authors:  D L Harris; R F Ross; W P Switzer
Journal:  Am J Vet Res       Date:  1969-09       Impact factor: 1.156

7.  Bioassay of endotoxin: correlation between pyrogenicity for rabbits and lethality for chick embryos.

Authors:  K C Milner; R A Finkelstein
Journal:  J Infect Dis       Date:  1966-12       Impact factor: 5.226

8.  Adenosine monophosphate as the first phosphoryl acceptor in oxidative phosphorylation.

Authors:  T Ozawa
Journal:  Arch Biochem Biophys       Date:  1966-11       Impact factor: 4.013

9.  Fine structural changes in the porcine nasal ciliated epithelial cell produced by Bordetella bronchiseptica rhinitis.

Authors:  J R Duncan; F K Ramsey
Journal:  Am J Pathol       Date:  1965-10       Impact factor: 4.307

10.  Studies on the ultrastructure of Bordetella pertussis. I. Morphology, origin, and biological activity of structures present in the extracellular fluid of liquid cultures of Bordetella pertussis.

Authors:  J H Morse; S I Morse
Journal:  J Exp Med       Date:  1970-06-01       Impact factor: 14.307

View more
  6 in total

1.  Influence of potential virulence determinants on Bordetella bronchiseptica-induced ciliostasis.

Authors:  D A Bemis; S A Wilson
Journal:  Infect Immun       Date:  1985-10       Impact factor: 3.441

Review 2.  Biology of Bordetella bronchiseptica.

Authors:  R A Goodnow
Journal:  Microbiol Rev       Date:  1980-12

3.  Experimental atrophic rhinitis in gnotobiotic pigs.

Authors:  O P Miniats; J A Johnson
Journal:  Can J Comp Med       Date:  1980-10

Review 4.  Human infections associated with Bordetella bronchiseptica.

Authors:  B F Woolfrey; J A Moody
Journal:  Clin Microbiol Rev       Date:  1991-07       Impact factor: 26.132

5.  Bordetella rhinitis in pigs: serum and nasal antibody response to Bordetella bacterins.

Authors:  A C Brandenburg
Journal:  Can J Comp Med       Date:  1978-01

6.  An agglutination test for the detection of Bordetella bronchiseptica infection in swine.

Authors:  E M Jenkins
Journal:  Can J Comp Med       Date:  1978-07
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.